Few reports of a regulatory IGF-IR/YAP1 axis have been published so far [32–34]: Zhou and colleagues reported an analogous mechanistic link in diffuse large B-cell lymphoma, demonstrating that IGF-IR inhibition decreased YAP1 expression and restrained the activation of YAP1 downstream targets [34]. This evidence concerns the gene IGF1R and diffuse large B-cell lymphoma.